These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1848294)

  • 1. Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides.
    Bradbury BJ; Baumgold J; Paek R; Kammula U; Zimmet J; Jacobson KA
    J Med Chem; 1991 Mar; 34(3):1073-9. PubMed ID: 1848294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.
    Bradbury BJ; Baumgold J; Jacobson KA
    J Med Chem; 1990 Feb; 33(2):741-8. PubMed ID: 2153827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Nilsson BM; Vargas HM; Hacksell U
    J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Lundkvist JR; Vargas HM; Caldirola P; Ringdahl B; Hacksell U
    J Med Chem; 1990 Dec; 33(12):3182-9. PubMed ID: 2258904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol.
    Carroll FI; Abraham P; Chemburkar S; He XC; Mascarella SW; Kwon YW; Triggle DJ
    J Med Chem; 1992 Jun; 35(12):2184-91. PubMed ID: 1613746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactam analogues of oxotremorine. 3- and 4-methyl-substituted 2-azetidinones.
    Nilsson BM; Ringdahl B; Hacksell U
    J Med Chem; 1990 Feb; 33(2):580-4. PubMed ID: 2299626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally restricted analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Lundkvist JR; Ringdahl B; Hacksell U
    J Med Chem; 1989 Apr; 32(4):863-9. PubMed ID: 2704032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5).
    Trybulski EJ; Kramss RH; Mangano RM; Rusinko A
    J Med Chem; 1990 Dec; 33(12):3190-8. PubMed ID: 2258905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.
    Baumgold J; Drobnick A
    Mol Pharmacol; 1989 Sep; 36(3):465-70. PubMed ID: 2550780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
    Aagaard P; McKinney M
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .
    Sauerberg P; Olesen PH; Nielsen S; Treppendahl S; Sheardown MJ; Honoré T; Mitch CH; Ward JS; Pike AJ; Bymaster FP
    J Med Chem; 1992 Jun; 35(12):2274-83. PubMed ID: 1613751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
    Evans T; Smith MM; Tanner LI; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
    Leader H; Gordon RK; Baumgold J; Boyd VL; Newman AH; Smejkal RM; Chiang PK
    J Med Chem; 1992 Apr; 35(7):1290-5. PubMed ID: 1560441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.
    Nilsson BM; Vargas HM; Ringdahl B; Hacksell U
    J Med Chem; 1992 Jan; 35(2):285-94. PubMed ID: 1732545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
    Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
    Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
    Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
    Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.
    Sauerberg P; Kindtler JW; Nielsen L; Sheardown MJ; Honoré T
    J Med Chem; 1991 Feb; 34(2):687-92. PubMed ID: 1995893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
    Dunbar PG; Durant GJ; Rho T; Ojo B; Huzl JJ; Smith DA; el-Assadi AA; Sbeih S; Ngur DO; Periyasamy S
    J Med Chem; 1994 Aug; 37(17):2774-82. PubMed ID: 8064804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.